Hamilton Locke Advises EMVision on $15.28M Strategic Placement with Keysight Technologies
Hamilton Locke is pleased to have advised EMVision Medical Devices Limited (ASX: EMV) on its $15.28 million strategic placement with Keysight Technologies Inc (NYSE: KEYS). The deal represents a significant milestone for EMVision, positioning the company for accelerated growth, market penetration, and continued innovation in medical imaging technology. The investment will facilitate and fund EMVision’s […]
